Acorah Software Products - Accounts Production 16.6.950 false true false true No description of principal activity 16 September 2024 30 September 2025 30 September 2025 15958106 Mr Andrew Brown iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15958106 2024-09-15 15958106 2025-09-30 15958106 2024-09-16 2025-09-30 15958106 frs-core:CurrentFinancialInstruments 2025-09-30 15958106 frs-bus:PrivateLimitedCompanyLtd 2024-09-16 2025-09-30 15958106 frs-bus:FilletedAccounts 2024-09-16 2025-09-30 15958106 frs-bus:Micro-entities 2024-09-16 2025-09-30 15958106 frs-bus:AuditExempt-NoAccountantsReport 2024-09-16 2025-09-30 15958106 frs-bus:Director1 2024-09-16 2025-09-30
Registered number: 15958106
Medicine Ip Consulting Ltd
Unaudited Financial Statements
For the Period 16 September 2024 to 30 September 2025
Balance Sheet
Registered number: 15958106
30 September 2025
£
Fixed assets 1,050
Current assets 107,985
Creditors: Amounts Falling Due Within One Year (35,451 )
NET CURRENT ASSETS 72,534
TOTAL ASSETS LESS CURRENT LIABILITIES 73,584
Accruals and deferred income (198 )
NET ASSETS 73,386
CAPITAL AND RESERVES 73,386

Notes

1. General Information
Medicine Ip Consulting Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15958106 . The registered office is 3 Victoria Parade, , Urmston,, Manchester, M41 9BP.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Andrew Brown
Director
19/01/2026